Press release: Trial confirms new antimalarial effectiveness


Press release: Trial confirms new antimalarial effectiveness

A large LSTM-led trial confirms new antimalarial, dihydroartemisinin-piperaquine, is more effective at preventing malaria than current WHO recommended treatment but does not improve adverse birth outcomes. Download the full press release here: